Association between expression of survivin and high-risk human papillomavirus infection in cervical cancer and precancerous tissues

Abstract

Abstract: Objective To investigate the expression of survivin and its association with high-risk human papillomavirus (HPV) infection in cervical cancer and precancerous tissues. Methods In 76 patients with cervical intraepithelial neoplasia (CIN) or cervical carcinoma, the expression of survivin was detected by immunohistochemistry and the infection rates of high-risk HPV including HPV16, 18, 31, 33, 52, and 58 were assayed by touch-down PCR, with 10 cases of normal cervical specimens serving as the control. Results Survivin expression tended to increase along with the tumor progression (P<0.05), and was associated with the histological grade of invasive carcinoma (P<0.05) but not with the patients’ age, clinical stage or histological classification (P>0.05). The positivity rate of high-risk HPV increased only in association with tumor progression (P<0.05) but not with the patients’ age, clinical stage or histological classification (P>0.05). Positive correlation between the expression of survivin and high-risk HPV infection was observed in cervical carcinoma. Conclusion Survivin might play an important role in the occurrence and development of cervical carcinoma in coordination with high-risk HPV.

CLC Number:

R737.33

LANG Yan¹, XIONG Yong-yan¹, CHEN Hui-zhen². Association between expression of survivin and high-risk human papillomavirus infection in cervical cancer and precancerous tissues[J]. Journal of Southern Medical University, 2005, 25(10): 1276-1279.

References

[1] 连利娟.林巧稚妇科肿瘤学[M].第3版,北京:人民卫生出版社,2000.209.
[2] Yoshinouch M, Hongo A, Kamoto N, et al. Alteration of the CDKN2/P16 gene is not required for HPV-positive uterine cervical cancer cell lines[J]. Iht J Oncol, 2000, 16(3): 537-41.
[3] Grossman D, McNiff JM, Li F, et al. Expression of the apoptosis inhibitor, surviving, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line[J]. Lab Invest, 1999, 79(9): 1121-6.
[4] Kim HS, Shiraki K, Rark SH, et al. Expression of survivin in CIN and invasive squamous cell carcinoma of uterine cervix [J].Anticancer Res, 2002, 22(2A): 805-8.
[5] 王梅,王冰,王晓丽,等.凋亡相关基因survivin在子宫颈癌组织中的表达及其与bcl-2、p53基因表达相关性的初步研究[J].中华妇产科杂志,2001,36(9):546-8.Wang M, Wang B, Wang XL, et al. A novel antiapoptosis gene,survivin, bcl-2, p53 expressed in cervical carcinoma [J]. Chin J Obstet Gynecol, 2001, 36(9): 546-8.
[6] 郑洪,侯文,胡琼.凋亡调控因子survivin和Caspase-3在宫颈上皮内瘤样变及宫颈癌中的表达及意义[J].贵州医药,2003,27(2):105-7.Zheng H, Hou W, Hu Q. Expression of apoptotic regulators surviving and effect or caspase-3 in cervical carcinoma and cervical intraepithelial neoplasia [J]. Guizhou Med J, 2003, 27(2): 105-7.
[7] Yoshida H, Sumi T, Hyum Y, et al. Expression of survivin and metrixmetalloproteinases in adenocarcinoma and squamous cell carcinoma of the uterine cervix[J]. Oncol Rep, 2003, 10(1): 45-9.
[8] 徐成康,梅卓贤.宫颈人类乳头状病毒感染的筛查及其意义[J].中山医科大学学报,1998,19(3):223-6.Xu CK, Mei ZX. Screening of human papilloma virus infection in cervix and its significance[J]. Acad J SUMS, 1998, 19(3): 223-6.
[9] Burd EM. Human papillomavirus and cervical carcer [J]. Clin Microbiol Rev, 2003, 16(1): 1-17.
[10] Arends MJ, Yvonne K, Donaldson YK, et al. Human papillomavirus type 18 associates with more advanced cervical neoplasia than human papillomavirus type 16[J]. Pathology, 1993, 24(4): 432-7.
[11] Frost M, Jarboe EA, Orlicky D, et al. Immunohistochemical localization of survivin in benign cervical mucosa, cervical dysplasia, and invasive squamous cell carcinoma[J]. Am J Clin Pathol, 2002, 117(5): 738-44.

[1]	. [J]. Journal of Southern Medical University, 2006, 26(12): 1772-1773.
[2]	ZHANG Yu1, ZHANG Yi1, LIN Qiu-hua2 1Department of Obstetrics and Gynecology, Xiangya Hospital, 2Department of Obstetrics and Gynecology, Second Xiangya Hospital, Central South University, Changsha 410078, China. Progesterone-modulated proteins in human endometrial cancer cell line Ishikawa [J]. Journal of Southern Medical University, 2006, 26(08): 1110-1113.
[3]	LU Jin-li1, YANG Fang2 Department of Radiotherapy, First Hospital1, Western District Library2, Xi’an Jiaotong University, Xi’ an 710061, China. Clinical pharmacokinetic study of cisplatin in enhancing cervical cancer radiosensitivity [J]. Journal of Southern Medical University, 2006, 26(08): 1170-1172.
[4]	. [J]. Journal of Southern Medical University, 2006, 26(08): 1248-1249.
[5]	GUO Sui-qun1, XING Fu-qi1, PANG Zhan-jun1, FANG Wei-yi2, LIU Guo-bing1 1Department of Gynaecology and Obstetrics, Nanfang Hospital, 2Institute of Cancer Research, Southern Medical University, Guangzhou 510515, China. Preliminary study of gene expression profiling in human type I and II endometrial carcinoma [J]. Journal of Southern Medical University, 2006, 26(06): 734-737.
[6]	WANG Ying, LI Xu, CHEN Wei Medical Laboratory Center, First Hospital of Xi’an Jiaotong University, Xi’an 710061, China. Expression, structure prediction and functional analysis of murine single-chain fragment vari- able antibody against human cervical cancer [J]. Journal of Southern Medical University, 2006, 26(01): 16-21.
[7]	LIU Guo-bing, LIU Xin, PANG Zhan-jun, XING Fu-qi. Significance of pelvic lymph node human papillomavirus DNA detection in cervical cancer [J]. Journal of Southern Medical University, 2005, 25(10): 1236-1239.
[8]	LIU Xin, LIU Guo-bing, PANG Zhan-jun, XING Fu-qi. Sequence polymorphism of human papillomavirus type 16 E7 in cervical cancer [J]. Journal of Southern Medical University, 2005, 25(10): 1272-1275.
[9]	ZHAO En-feng¹, BAO Lei², LI Chao, SONG Lei³, LI Ya-li¹. Changes in epidemiology and clinical characteristics of cervical cancer over the past 50 years [J]. Journal of Southern Medical University, 2005, 25(06): 605-609.
[10]	ZHENG Xiao-kang¹, CHEN Long-hua¹, LI Jian². Radiotherapeutic effect and prognosis of bulky exophytic cervical cancer [J]. Journal of Southern Medical University, 2005, 25(03): 332-334,338.
[11]	ZHOU Jin¹, CHEN Shi-ling¹, XING Fu-qi¹, PANG Zhan-jun¹, LI Bing², ZHOU Wen-qu², FU Xin², DING Yan-qing³. Association of the novel hydatidiform mole-related gene F10 with the invasiveness of trophoblastic tumor [J]. Journal of Southern Medical University, 2005, 25(02): 171-173.
[12]	. Diagnostic analysis of two sister pairs with endometrial cancer [J]. Journal of Southern Medical University, 2005, 25(02): 239-240.
[13]	LIU Ke¹, WANG Li-li², SUN Fang¹, ZHENG Yan-fang³, ZHANG Ji-ren³. Effect of anti-HPV16 E6-ribozyme on cell proliferation and invasiveness of cervical carcinoma cell line CaSKi [J]. Journal of Southern Medical University, 2004, 24(12): 1367-1372.
[14]	ZHOU Rui-li, LIU Guo-bing. Age and prognosis: analysis of their association in 93 cases of cervical cancer [J]. Journal of Southern Medical University, 2004, 24(09): 1066-1067.
[15]	ZHANG Guang-liang¹, LIU Guo-bing¹, HUANG Qi-li², XING Fu-qi¹. Comparative study of the impacts of laparoscopic and open laparotomic surgeries on oxidative stress in patients with uterine myomas [J]. Journal of Southern Medical University, 2004, 24(08): 907-909.